Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development

Journal: Nature Communications

Published: 2020-09-23

DOI: 10.1038/s41467-020-18528-z

Affiliations: 20

Authors: 29

Go to article
Institutions Share
Center for Advanced Vision Science (CAVS), UVA, United States of America (USA) 0.25
Department of Ophthalmology, UVA, United States of America (USA) 0.25
Department of Pharmacology, UVA, United States of America (USA) 0.07
College of Pharmacy, SC, United States of America (USA) 0.06
Dorn Research Institute, United States of America (USA) 0.06
Columbia VA Health Care System, United States of America (USA) 0.06
Department of Epidemiology and Biostatistics, SC, United States of America (USA) 0.03
UK Department of Ophthalmology and Visual Sciences, United States of America (USA) 0.03
Department of Medical Statistics, University of Göttingen, Germany 0.03
Department of Orthopaedic Surgery, UVA, United States of America (USA) 0.03
Department of Ophthalmology and Visual Sciences, U-M, United States of America (USA) 0.03
Institute for Healthcare Policy and Innovation (IHPI), U-M, United States of America (USA) 0.02
Department of Pathology, UVA, United States of America (USA) 0.02
Faculty of Medicine, University of Tsukuba, Japan 0.01
Department of Health Management and Policy (HMP), U-M, United States of America (USA) 0.01
Department of Biomedical Engineering (BME), UVA, United States of America (USA) 0.01
Department of Microbiology, Immunology, and Cancer Biology (MIC), UVA, United States of America (USA) 0.01
Department of Neuroscience, UVA, United States of America (USA) 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER